Inositol 1,3,4,5-Tetrakisphosphate Negatively Regulates Phosphatidylinositol-3,4,5- Trisphosphate Signaling in Neutrophils
- 1 September 2007
- Vol. 27 (3) , 453-467
- https://doi.org/10.1016/j.immuni.2007.07.016
Abstract
No abstract availableKeywords
Funding Information
- American Cancer Society
- National Institutes of Health (GM076084, HL066987, HL085100, NS052200)
This publication has 108 references indexed in Scilit:
- Chromogranin-A and N-Terminal Pro-Brain Natriuretic Peptide: An Excellent Pair of Biomarkers for Diagnostics in Patients With Neuroendocrine TumorJournal of Clinical Oncology, 2009
- Chromogranin A as an Alternative to 5-Hydroxyindoleacetic Acid in the Evaluation of Symptoms during Treatment of Patients with Neuroendocrine TumorsNeuroendocrinology, 2008
- Inositol 1,3,4,5-tetrakisphosphate controls proapoptotic Bim gene expression and survival in B cellsProceedings of the National Academy of Sciences, 2007
- Tumor suppressor PTEN is a physiologic suppressor of chemoattractant-mediated neutrophil functionsBlood, 2007
- Deactivation of phosphatidylinositol 3,4,5-trisphosphate/Akt signaling mediates neutrophil spontaneous deathProceedings of the National Academy of Sciences, 2006
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005
- Metastatic Carcinoid Tumors: A Clinical ReviewThe Oncologist, 2005
- Model-Based Clustering, Discriminant Analysis, and Density EstimationJournal of the American Statistical Association, 2002
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- Characterization of a gastrin releasing peptide from porcine non-antral gastric tissueBiochemical and Biophysical Research Communications, 1979